Toxicology Knowledge Team Sweden

TKT Sweden (Toxicology Knowledge Team Sweden AB), founded in 2012 by former AstraZeneca toxicologists, is one of the largest toxicology consulting firms in the Nordic region. The company specializes in providing expert support for drug development, chemical risk assessment, regulatory compliance (including REACH & CLP), impurity/toxicological evaluation, and safety pharmacology. In April 2021 it was acquired by Center for Translational Research Sweden AB (CTR). The team includes several PhD-level toxicologists with broad expertise across pharmaceutical and medical device projects. Operations continue under CTR ownership with no interruption to staff or services. As of March 2022, Suzanne Iverson Hemberg became CEO. The firm’s consultants are recognized experts in metabolism studies, genetic/environmental/respiratory toxicology, safety pharmacology, project management with regulatory authorities (EU focus), study outsourcing oversight and more. Clients include pharma companies seeking support from early discovery through regulatory submission. No internal R&D pipeline or proprietary drugs. Not a manufacturer but provides manufacturing-related risk assessments. Locations remain unchanged post-acquisition—Södertälje/Stockholm area.